Oct 08, 2024 Introduction to the DLA Piper Genomics Series: An Insight into the ‘Genomics Revolution’ By Marion Abecassis Lyndsey Hudson Kate Black Ruth Faragher +1 more... Show less Introduction Over the next 2 months, the DLA Piper Life Sciences Blog: Cortex will feature a series of articles providing an insight into...
Dec 10, 2024 Poland - Life Sciences Monthly Brief, November 2024 By DLA Piper Life Sciences Download a copy of our July monthly briefing, which covers key updates and insights in the following areas: Medicinal products;Medical...
Dec 10, 2024 Life Sciences News in Italy: November 2024 By DLA Piper Life Sciences Regulatory MDCG updates Q&A on vigilance terms under MDR and IVDR On 11 November 2024, the Medical Device Coordination Group (MDCG)...
Dec 04, 2024 What should in-scope organisations do now to prepare for NIS2 compliance? By Cristina Criscuoli Federico Toscani Introduction In our second Network and Information Systems Directive (NIS2 Directive or Directive) article, we discuss the significant...
Dec 04, 2024 DLA Piper Genomics Series: Shaping the Future of Genomics - How Governments Worldwide Are Driving the Shift to Personalised Medicine By Kate Black As our Genomics mini-series has been exploring to date, genomic medicine is rapidly transforming healthcare across the globe, offering...
Nov 20, 2024 EHDS – Access to health data for secondary use under the European Health Data Space By Andreas Rüdiger James Clark This is Part 3 in a series of articles on the European Health Data Space ("EHDS"). Part 1 provides a general overview of the EHDS. Part...
Nov 19, 2024 DLA Piper Genomics Series: The UAE turns to genomics to provide world-class healthcare services By Adam Vause Celia Johnson-Morgan Katie Edwards Harnessing genomic technologies is revolutionising patient care by powering the evolution of personalised and precision medicine. The...
Nov 12, 2024 DLA Piper Genomics Series: CRISPR/Cas patent disputes – the position in Australia By Nicholas Tyacke Alex May The development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein (Cas) systems for genome...
Nov 05, 2024 Poland - Life Sciences Monthly Brief, October 2024 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our July monthly briefing, which covers key updates and insights in the following areas: Medicinal products;Medical...
Oct 31, 2024 Medicines Australia Code of Conduct – New Edition Released By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Hazel Pang +1 more... Show less On 30 October 2024, Medicines Australia (MA) formally adopted a new edition (Edition 20) of the MA Code of Conduct (MA Code), which will...
Oct 31, 2024 DLA Piper Genomics Series: From Gene-Edited Plants to Gene Drives: Unpacking Regulatory Debates By Mikael Kurki Pia Riemenschneider Lisa Weinekötter In this two-part article, we delve into the complexities of gene editing in plants and the ongoing EU legislative debates, followed by an...
Oct 29, 2024 UK DHSC seeks circular approach to medtech By Richard Taylor Nathan Davis The UK's Department of Health and Social Care (DHSC) has published its "Design for Life" roadmap towards a circular approach to medtech...
Oct 28, 2024 NIS2 Series, Part 1 - Key features of the EU's new cybersecurity law and how it will apply to the life sciences sector By Nicholas de Lacy-Brown Abstract: The EU has expressly recognised the criticality of the life sciences sector by bringing pharmaceutical manufacturers, clinical...
Oct 24, 2024 DLA Piper Genomics Series: Navigating Regulatory Challenges in the Era of Cell and Gene Therapies By Marion Abecassis Lyndsey Hudson Nicola Landolfi Ranulf Barman Marion de Galembert +2 more... Show less As healthcare moves towards personalised and precision medicine,[2] cell and gene therapies (CGTs) have emerged as cutting-edge and...
Oct 21, 2024 2024 UK Healthtech Survey: balancing significant challenges with opportunities By Ataikor Ngerebara The 2024 Pulse of the Sector Survey conducted by Association of British HealthTech Industries (ABHI) and Centre for Process Innovation...
Oct 15, 2024 DLA Piper Genomics Series: From crisp packets to CRISPR, and beyond By Rebecca Lawrence Genome editing is an immensely powerful tool which has the potential to revolutionise the life sciences, including medicine and...
Oct 11, 2024 England's CQC under fire: Significant failings identified in new single assessment framework By Poppy Williams Teresa Hitchcock A recent review by Dr Penny Dash, known as the 'Dash Report', has identified significant failings in England's Care Quality Commission...